Cancer Research And Biostatistics, Seattle, Washington.
Department of Thoracic and Vascular Surgery, Antwerp University Hospital and University of Antwerp, Edegem, Belgium.
J Thorac Oncol. 2018 Jun;13(6):801-809. doi: 10.1016/j.jtho.2018.02.012. Epub 2018 Feb 22.
Over the past two decades, the International Association for the Study of Lung Cancer (IASLC) Staging Project has been a steady source of evidence-based recommendations for the TNM classification for lung cancer published by the Union for International Cancer Control and the American Joint Committee on Cancer. The Staging and Prognostic Factors Committee of the IASLC is now issuing a call for participation in the next phase of the project, which is designed to inform the ninth edition of the TNM classification for lung cancer. Following the case recruitment model for the eighth edition database, volunteer site participants are asked to submit data on patients whose lung cancer was diagnosed between January 1, 2011, and December 31, 2019, to the project by means of a secure, electronic data capture system provided by Cancer Research And Biostatistics in Seattle, Washington. Alternatively, participants may transfer existing data sets. The continued success of the IASLC Staging Project in achieving its objectives will depend on the extent of international participation, the degree to which cases are entered directly into the electronic data capture system, and how closely externally submitted cases conform to the data elements for the project.
在过去的二十年中，国际肺癌研究协会（IASLC）分期项目一直是为国际癌症控制联盟和美国癌症联合委员会发布的肺癌 TNM 分类提供循证建议的稳定来源。IASLC 分期和预后因素委员会现呼吁参与该项目的下一阶段，旨在为肺癌的第九版 TNM 分类提供信息。该项目遵循第八版数据库的病例招募模式，要求志愿站点参与者通过华盛顿州西雅图的癌症研究与生物统计学提供的安全电子数据采集系统，向项目提交其在 2011 年 1 月 1 日至 2019 年 12 月 31 日期间诊断为肺癌的患者数据。或者，参与者可以转移现有的数据集。IASLC 分期项目要想成功实现其目标，将取决于国际参与的程度、病例直接输入电子数据采集系统的程度以及外部提交的病例与项目数据元素的吻合程度。
